Logo image of NTLA

INTELLIA THERAPEUTICS INC (NTLA) Stock Earnings & Estimates

NASDAQ:NTLA - US45826J1051 - Common Stock

12.06 USD
+0.44 (+3.79%)
Last: 9/5/2025, 8:00:02 PM
12.09 USD
+0.03 (+0.25%)
After Hours: 9/5/2025, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
NTLA revenue by date.NTLA revenue by date.
52.12M
57.70%
36.275M
-30.40%
57.877M
59.55%
62.693M
8.32%
53.268M
-15.03%
70.809M
32.93%
910.13M
1,185.33%
1.876B
106.12%
2.771B
47.71%
1.417B
-48.86%
1.958B
38.18%
EBITDA
YoY % growth
NTLA ebitda by date.NTLA ebitda by date.
-450.59M
-72.67%
-506.315M
-12.37%
-523.978M
-3.49%
-456.406M
12.90%
-465.018M
-1.89%
-460.748M
0.92%
-380.46M
17.43%
-63.24M
83.38%
445.74M
804.84%
857.82M
92.45%
1.191B
38.84%
EBIT
YoY % growth
NTLA ebit by date.NTLA ebit by date.
-458.16M
-71.05%
-515.291M
-12.47%
-534.263M
-3.68%
-463.623M
13.22%
-463.509M
0.02%
-466.182M
-0.58%
66.008M
114.16%
581.51M
780.97%
1.16B
99.48%
377.31M
-67.47%
637.33M
68.91%
Operating Margin
NTLA operating margin by date.NTLA operating margin by date.
-879.05%-1,420.51%-923.10%-739.51%-870.15%-658.37%7.25%31.00%41.86%26.63%32.55%
EPS
YoY % growth
NTLA eps by date.NTLA eps by date.
-6.18
-64.36%
-5.41
12.46%
-5.25
2.96%
-4.17
20.59%
-3.97
4.75%
-3.71
6.46%
1.85
149.79%
7.55
308.00%
13.69
81.44%
4.51
-67.05%
6.67
47.94%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-1.02
23.72%
-1.02
19.89%
-1.08
2.16%
-1.11
-13.01%
-1.14
-11.06%
-1.06
-4.63%
0.01
101.30%
0.02
101.45%
0.04
103.55%
0.05
104.53%
Revenue
Q2Q % growth
14.58M
60.03%
19.318M
50.05%
12.009M
-27.77%
10.592M
-25.64%
10.084M
-30.84%
10.094M
-47.75%
217.66M
1,712.47%
226.8M
2,041.24%
233.02M
2,210.79%
240.97M
2,287.26%
EBITDA
Q2Q % growth
-106.08M
22.60%
-103.02M
18.34%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-104.716M
27.67%
-103.043M
24.48%
-125.292M
-3.71%
-128.255M
-16.60%
-127.9M
-22.14%
-121.419M
-17.83%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.98
35.53%
-1.040.065.61%
Q1 2025
Q2Q % growth
-1.10
1.79%
-1.310.2115.91%
Q4 2024
Q2Q % growth
-1.27
13.01%
-1.360.096.34%
Q3 2024
Q2Q % growth
-1.34
2.90%
-1.410.075.12%
Q2 2024
Q2Q % growth
-1.52
-8.57%
-1.26-0.26-20.94%
Q1 2024
Q2Q % growth
-1.12
4.27%
-1.410.2920.41%
Q4 2023
Q2Q % growth
-1.46
-4.29%
-1.480.021.23%
Q3 2023
Q2Q % growth
-1.38
7.38%
-1.530.159.73%
Q2 2023
Q2Q % growth
-1.40
-5.26%
-1.35-0.05-3.91%
Q1 2023
Q2Q % growth
-1.17
40.31%
-1.430.2618.08%
Q4 2022
Q2Q % growth
-1.40
-28.44%
-1.420.021.45%
Q3 2022
Q2Q % growth
-1.49
-53.61%
-1.31-0.18-13.96%
Q2 2022
Q2Q % growth
-1.33
-31.68%
-1.330.000.17%
Q1 2022
Q2Q % growth
-1.96
-184.06%
-1.13-0.83-73.90%
Q4 2021
Q2Q % growth
-1.09
-57.97%
-0.96-0.13-13.14%
Q3 2021
Q2Q % growth
-0.97
-106.38%
-0.86-0.11-12.71%
Q2 2021
Q2Q % growth
-1.01
-65.57%
-0.65-0.36-56.35%
Q1 2021
Q2Q % growth
-0.69
-9.52%
-0.67-0.02-2.83%
Q4 2020
Q2Q % growth
-0.69
-21.05%
-0.61-0.08-12.32%
Q3 2020
Q2Q % growth
-0.47
4.08%
-0.600.1321.98%
Q2 2020
Q2Q % growth
-0.61
-8.93%
-0.700.0913.41%
Q1 2020
Q2Q % growth
-0.63
-28.57%
-0.43-0.20-45.52%
Q4 2019
Q2Q % growth
-0.57 -0.570.000.65%
Q3 2019
Q2Q % growth
-0.49 -0.630.1422.37%
Q2 2019
Q2Q % growth
-0.56 -0.610.058.91%
Q1 2019
Q2Q % growth
-0.49 -0.600.1118.83%
NTLA Yearly EPS VS EstimatesNTLA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 10 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
14.245M
104.76%
12.402M1.843M14.86%
Q1 2025
Q2Q % growth
16.627M
-42.54%
12.111M4.516M37.29%
Q4 2024
Q2Q % growth
12.874M
771.57%
8.703M4.171M47.93%
Q3 2024
Q2Q % growth
9.111M
-24.02%
8.013M1.098M13.70%
Q2 2024
Q2Q % growth
6.957M
-48.82%
19.545M-12.588M-64.41%
Q1 2024
Q2Q % growth
28.935M
129.53%
11.734M17.201M146.59%
Q4 2023
Q2Q % growth
-1.917M
-114.13%
13.082M-14.999M-114.65%
Q3 2023
Q2Q % growth
11.992M
-9.63%
12.697M-705K-5.55%
Q2 2023
Q2Q % growth
13.594M
-3.11%
12.319M1.275M10.35%
Q1 2023
Q2Q % growth
12.606M
12.05%
12.063M543K4.50%
Q4 2022
Q2Q % growth
13.57M
5.60%
11.558M2.012M17.41%
Q3 2022
Q2Q % growth
13.27M
84.31%
11.569M1.701M14.70%
Q2 2022
Q2Q % growth
14.03M
114.20%
9.602M4.428M46.12%
Q1 2022
Q2Q % growth
11.25M
74.42%
8.715M2.535M29.09%
Q4 2021
Q2Q % growth
12.85M
94.70%
8.426M4.424M52.50%
Q3 2021
Q2Q % growth
7.2M
-67.60%
8.837M-1.637M-18.52%
Q2 2021
Q2Q % growth
6.55M
-59.72%
12.128M-5.578M-45.99%
Q1 2021
Q2Q % growth
6.45M
-50.08%
10.055M-3.605M-35.85%
Q4 2020
Q2Q % growth
6.6M
-39.67%
14.377M-7.777M-54.09%
Q3 2020
Q2Q % growth
22.22M
109.23%
15.896M6.324M39.78%
Q2 2020
Q2Q % growth
16.26M
46.22%
8.716M7.544M86.55%
Q1 2020
Q2Q % growth
12.92M
23.87%
19.782M-6.862M-34.69%
Q4 2019
Q2Q % growth
10.94M 10.137M803K7.92%
Q3 2019
Q2Q % growth
10.62M 9.615M1.005M10.45%
Q2 2019
Q2Q % growth
11.12M 7.257M3.863M53.23%
Q1 2019
Q2Q % growth
10.43M 7.757M2.673M34.46%
NTLA Yearly Revenue VS EstimatesNTLA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.95% 20.99% 2.05% 2.63%
Revenue15.22% 29.42% 8.67% 8.57%